A new definition and refocus of pharmaceutical care: the Barbate Document.

Objective: To propose an updated definition of Pharmaceutical Care based on  the Capacity-Motivation-Opportunity (CMO) model and on the key elements and  optimal activities for its development that guarantee the highest levels of quality and excellence in this professional activity.

Method: The consensus was developed by a working group composed of  members of the Spanish Society of Hospital Pharmacy and other pharmacists from different healthcare fields. A literature review of PubMed was  conducted of the available scientific evidence on pharmaceutical healthcare  models and activities with the greatest impact and ease of implementation. A  working definition was developed and the initiatives chosen as key elements  were collected and included in each pillar of the proposed model. After creating  an initial list of activities and terms, the working group reviewed it and made  corrections or proposed new activities. In addition, the definitions of the three  key elements of the CMO model were agreed upon: Capacity-Motivation- Opportunity. In order to incorporate all appropriate suggestions and  contributions before finalizing the consensus, the final draft was sent to the  different scientific, pharmaceutical, and medical societies as well as patient  associations with which the Spanish Society of Hospital Pharmacy has a  collaboration agreement.

Results: The definition of consensual Pharmaceutical Care was "Any  professional activity by which the pharmacist is linked to the patient (and/or caregiver) and other healthcare professionals, to attend to the patient  according to their needs, setting out strategies to align and achieve the shortand medium-/long-term objectives of pharmacotherapy and incorporating new technologies and the means available to continuously interact  with ment was reached on the definitions of the three key elements of the CMO model. Finally, 27 key elements for the development of pharmaceutical activity were identified and included in the three pillars of the  model.

Conclusions: A new definition of Pharmaceutical Care has been agreed upon  that refocuses this professional activity, allowing us to advance within the  multidisciplinary working approach toward a longitudinal and multidimensional  approach to the patient.